Go Pro

BIO-key International (BKYI) Competitors

BIO-key International logo
$2.82 -0.11 (-3.75%)
As of 03:39 PM Eastern

BKYI vs. INTZ, AUID, ARQQW, BTQ, and MSFT

Should you buy BIO-key International stock or one of its competitors? BIO-key International's main competitors and comparable companies include Intrusion (INTZ), authID (AUID), Arqit Quantum (ARQQW), BTQ Technologies (BTQ), and Microsoft (MSFT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "systems software" industry.

How does BIO-key International compare to Intrusion?

BIO-key International (NASDAQ:BKYI) and Intrusion (NASDAQ:INTZ) are both small-cap technology companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, risk, dividends, institutional ownership, profitability, valuation, analyst recommendations and media sentiment.

BIO-key International has a beta of 0.4, indicating that its stock price is 60% less volatile than the broader market. Comparatively, Intrusion has a beta of -1.55, indicating that its stock price is 255% less volatile than the broader market.

BIO-key International has higher earnings, but lower revenue than Intrusion. Intrusion is trading at a lower price-to-earnings ratio than BIO-key International, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BIO-key International$6.09M0.67-$7.16M-$4.11N/A
Intrusion$7.09M2.86-$9.06M-$0.55N/A

In the previous week, Intrusion had 8 more articles in the media than BIO-key International. MarketBeat recorded 11 mentions for Intrusion and 3 mentions for BIO-key International. Intrusion's average media sentiment score of 0.67 beat BIO-key International's score of 0.23 indicating that Intrusion is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BIO-key International
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Intrusion
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Intrusion has a consensus price target of $5.25, suggesting a potential upside of 534.52%. Given Intrusion's stronger consensus rating and higher probable upside, analysts plainly believe Intrusion is more favorable than BIO-key International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BIO-key International
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Intrusion
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

26.5% of BIO-key International shares are held by institutional investors. Comparatively, 19.4% of Intrusion shares are held by institutional investors. 4.0% of BIO-key International shares are held by company insiders. Comparatively, 10.1% of Intrusion shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

BIO-key International has a net margin of -50.01% compared to Intrusion's net margin of -191.24%. BIO-key International's return on equity of -67.31% beat Intrusion's return on equity.

Company Net Margins Return on Equity Return on Assets
BIO-key International-50.01% -67.31% -40.28%
Intrusion -191.24%-178.06%-99.59%

Summary

Intrusion beats BIO-key International on 9 of the 16 factors compared between the two stocks.

How does BIO-key International compare to authID?

authID (NASDAQ:AUID) and BIO-key International (NASDAQ:BKYI) are both small-cap technology companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, media sentiment, analyst recommendations, valuation and risk.

BIO-key International has a net margin of -50.01% compared to authID's net margin of -934.06%. BIO-key International's return on equity of -67.31% beat authID's return on equity.

Company Net Margins Return on Equity Return on Assets
authID-934.06% -297.48% -213.83%
BIO-key International -50.01%-67.31%-40.28%

BIO-key International has higher revenue and earnings than authID. BIO-key International is trading at a lower price-to-earnings ratio than authID, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
authID$2.04M3.28-$17.93M-$1.23N/A
BIO-key International$6.09M0.67-$7.16M-$4.11N/A

In the previous week, BIO-key International had 1 more articles in the media than authID. MarketBeat recorded 3 mentions for BIO-key International and 2 mentions for authID. authID's average media sentiment score of 0.38 beat BIO-key International's score of 0.23 indicating that authID is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
authID
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BIO-key International
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
authID
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
BIO-key International
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

8.8% of authID shares are held by institutional investors. Comparatively, 26.5% of BIO-key International shares are held by institutional investors. 17.4% of authID shares are held by company insiders. Comparatively, 4.0% of BIO-key International shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

authID has a beta of 1.56, indicating that its stock price is 56% more volatile than the broader market. Comparatively, BIO-key International has a beta of 0.4, indicating that its stock price is 60% less volatile than the broader market.

Summary

BIO-key International beats authID on 8 of the 14 factors compared between the two stocks.

How does BIO-key International compare to Arqit Quantum?

BIO-key International (NASDAQ:BKYI) and Arqit Quantum (NASDAQ:ARQQW) are both technology companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, dividends, profitability, risk and valuation.

Arqit Quantum has lower revenue, but higher earnings than BIO-key International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BIO-key International$6.09M0.67-$7.16M-$4.11N/A
Arqit Quantum$1.09MN/AN/AN/AN/A

Arqit Quantum has a net margin of 0.00% compared to BIO-key International's net margin of -50.01%. Arqit Quantum's return on equity of 0.00% beat BIO-key International's return on equity.

Company Net Margins Return on Equity Return on Assets
BIO-key International-50.01% -67.31% -40.28%
Arqit Quantum N/A N/A N/A

26.5% of BIO-key International shares are held by institutional investors. 4.0% of BIO-key International shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

In the previous week, BIO-key International had 1 more articles in the media than Arqit Quantum. MarketBeat recorded 3 mentions for BIO-key International and 2 mentions for Arqit Quantum. Arqit Quantum's average media sentiment score of 0.33 beat BIO-key International's score of 0.23 indicating that Arqit Quantum is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BIO-key International
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Arqit Quantum
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BIO-key International
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
Arqit Quantum
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Summary

BIO-key International beats Arqit Quantum on 5 of the 9 factors compared between the two stocks.

How does BIO-key International compare to BTQ Technologies?

BIO-key International (NASDAQ:BKYI) and BTQ Technologies (NASDAQ:BTQ) are both technology companies, but which is the better business? We will compare the two businesses based on the strength of their risk, media sentiment, valuation, institutional ownership, earnings, dividends, profitability and analyst recommendations.

BTQ Technologies has a net margin of 0.00% compared to BIO-key International's net margin of -50.01%. BTQ Technologies' return on equity of 0.00% beat BIO-key International's return on equity.

Company Net Margins Return on Equity Return on Assets
BIO-key International-50.01% -67.31% -40.28%
BTQ Technologies N/A N/A N/A

In the previous week, BTQ Technologies had 1 more articles in the media than BIO-key International. MarketBeat recorded 4 mentions for BTQ Technologies and 3 mentions for BIO-key International. BIO-key International's average media sentiment score of 0.23 beat BTQ Technologies' score of 0.00 indicating that BIO-key International is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BIO-key International
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BTQ Technologies
0 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

BTQ Technologies has lower revenue, but higher earnings than BIO-key International.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BIO-key International$6.09M0.67-$7.16M-$4.11N/A
BTQ TechnologiesN/AN/AN/AN/AN/A

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BIO-key International
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50
BTQ Technologies
0 Sell rating(s)
0 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
3.00

26.5% of BIO-key International shares are held by institutional investors. 4.0% of BIO-key International shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Summary

BTQ Technologies beats BIO-key International on 6 of the 10 factors compared between the two stocks.

How does BIO-key International compare to Microsoft?

Microsoft (NASDAQ:MSFT) and BIO-key International (NASDAQ:BKYI) are both technology companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk and dividends.

Microsoft has a net margin of 40.31% compared to BIO-key International's net margin of -50.01%. Microsoft's return on equity of 31.98% beat BIO-key International's return on equity.

Company Net Margins Return on Equity Return on Assets
Microsoft40.31% 31.98% 18.70%
BIO-key International -50.01%-67.31%-40.28%

In the previous week, Microsoft had 218 more articles in the media than BIO-key International. MarketBeat recorded 221 mentions for Microsoft and 3 mentions for BIO-key International. Microsoft's average media sentiment score of 0.83 beat BIO-key International's score of 0.23 indicating that Microsoft is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Microsoft
123 Very Positive mention(s)
29 Positive mention(s)
43 Neutral mention(s)
19 Negative mention(s)
4 Very Negative mention(s)
Positive
BIO-key International
0 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

Microsoft has higher revenue and earnings than BIO-key International. BIO-key International is trading at a lower price-to-earnings ratio than Microsoft, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Microsoft$331.84B11.41$133.75B$17.9628.40
BIO-key International$6.09M0.67-$7.16M-$4.11N/A

71.1% of Microsoft shares are owned by institutional investors. Comparatively, 26.5% of BIO-key International shares are owned by institutional investors. 0.0% of Microsoft shares are owned by insiders. Comparatively, 4.0% of BIO-key International shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Microsoft has a beta of 1.11, meaning that its stock price is 11% more volatile than the broader market. Comparatively, BIO-key International has a beta of 0.4, meaning that its stock price is 60% less volatile than the broader market.

Microsoft currently has a consensus target price of $562.49, indicating a potential upside of 10.27%. Given Microsoft's stronger consensus rating and higher possible upside, analysts plainly believe Microsoft is more favorable than BIO-key International.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Microsoft
0 Sell rating(s)
5 Hold rating(s)
42 Buy rating(s)
0 Strong Buy rating(s)
2.89
BIO-key International
1 Sell rating(s)
1 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.50

Summary

Microsoft beats BIO-key International on 15 of the 16 factors compared between the two stocks.

Get BIO-key International News Delivered to You Automatically

Sign up to receive the latest news and ratings for BKYI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding BKYI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BKYI vs. The Competition

MetricBIO-key InternationalSoftware IndustryTechnology SectorNASDAQ Exchange
Market Cap$4.21M$15.72B$29.51B$12.73B
Dividend YieldN/A3.40%2.73%8.86%
P/E Ratio-0.69139.9275.8025.38
Price / Sales0.671,293.98591.9892.60
Price / CashN/A45.8947.3252.26
Price / Book0.937.459.296.14
Net Income-$7.16M$437.25M$678.51M$349.01M
7 Day Performance-9.03%-1.84%-2.37%-1.47%
1 Month Performance-25.00%3.26%1.09%2.47%
1 Year Performance-62.81%4.92%186.43%15.84%

BIO-key International Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BKYI
BIO-key International
1.3265 of 5 stars
$2.82
-3.8%
N/A-60.9%$4.21M$6.09MN/A50
INTZ
Intrusion
3.8215 of 5 stars
$0.64
+5.8%
$5.25
+726.8%
-49.1%$15.56M$7.09MN/A60
AUID
authID
1.0527 of 5 stars
$0.49
+4.4%
N/A-90.4%$8.21M$2.04MN/A60
ARQQW
Arqit Quantum
N/A$0.01
+22.5%
N/A-98.4%$0.00$1.09MN/A147
BTQ
BTQ Technologies
N/A$3.33
-2.5%
N/A+7.6%$0.00N/AN/AN/A

Related Companies and Tools


This page (NASDAQ:BKYI) was last updated on 9/3/2026 by MarketBeat.com Staff.
From Our Partners